Serum CD14 levels in polytraumatized and severely burned patients
- PMID: 1713813
- PMCID: PMC1535761
- DOI: 10.1111/j.1365-2249.1991.tb05722.x
Serum CD14 levels in polytraumatized and severely burned patients
Abstract
Recently it has been demonstrated that the CD14 molecule which is expressed on monocytes and macrophages serves as a receptor for lipopolysaccharide (LPS) bound to LPS-binding protein (LBP) and thus mediates LPS-induced tumour necrosis factor (TNF) production. Here we report that CD14 is found as a soluble (s) molecule in serum. In healthy volunteers sCD14 levels (mean +/- s.e.m.) were 3.7 +/- 0.05 micrograms/ml (n = 30, 25-50 years of age) as determined by ELISA (detection limit 20 ng/ml serum) using two monoclonal antibodies in a sandwich technique. In polytraumatized patients (n = 16) significantly decreased levels (1.7 +/- 0.3) were detected immediately after the trauma, which increased to 4.9 +/- 0.3 micrograms/ml within the first 6 days post trauma. sCD14 remained elevated during the first 14 days post trauma in patients with the most severe injuries (injury severity score greater than 45 points), whereas a return to normal levels was observed in patients with an injury score of less than 45 points. In addition, the levels of the high-density lipoproteins that partially inactivate free endotoxin are significantly decreased post trauma. No correlation between parameters of inflammation (C3a and neopterin levels, leucocyte counts, amount of band cells), liver function and sCD14 levels was established. Comparable to polytraumatized patients, increased sCD14 serum levels were observed in five patients with burn trauma (burned area greater than 35%) within the second week post trauma when clinical signs of septicaemia were evident.
Similar articles
-
Endotoxin-neutralizing capacity of soluble CD14.Res Immunol. 1992 Jan;143(1):71-8. doi: 10.1016/0923-2494(92)80082-v. Res Immunol. 1992. PMID: 1373513
-
[Liberation of soluble CD14 (sCD 14) in plasma of trauma patients].Unfallchirurg. 1997 Oct;100(10):805-10. doi: 10.1007/s001130050197. Unfallchirurg. 1997. PMID: 9446236 German.
-
Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells.Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9887-91. doi: 10.1073/pnas.90.21.9887. Proc Natl Acad Sci U S A. 1993. PMID: 7694295 Free PMC article.
-
Prolonged interferon-gamma application by subcutaneous infusion in cancer patients: differential response of serum CD14, neopterin, and monocyte HLA class I and II antigens.J Interferon Res. 1992 Apr;12(2):103-11. doi: 10.1089/jir.1992.12.103. J Interferon Res. 1992. PMID: 1374454
-
Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation.Immunobiology. 1993 Apr;187(3-5):227-32. doi: 10.1016/S0171-2985(11)80341-4. Immunobiology. 1993. PMID: 7687234 Review.
Cited by
-
Anti-CD14 antibodies reduce responses of cultured human endothelial cells to endotoxin.Immunology. 1993 Sep;80(1):78-83. Immunology. 1993. PMID: 7503948 Free PMC article.
-
Endotoxin binding and elimination by monocytes: secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria.Infect Immun. 1998 Mar;66(3):1135-41. doi: 10.1128/IAI.66.3.1135-1141.1998. Infect Immun. 1998. PMID: 9488406 Free PMC article.
-
Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage.Gut. 2000 May;46(5):725-31. doi: 10.1136/gut.46.5.725. Gut. 2000. PMID: 10764720 Free PMC article.
-
Soluble CD14 activates monocytic cells independently of lipopolysaccharide.Infect Immun. 1998 May;66(5):2264-71. doi: 10.1128/IAI.66.5.2264-2271.1998. Infect Immun. 1998. PMID: 9573116 Free PMC article.
-
Lipopolysaccharide binding protein and sCD14 are not produced as acute phase proteins in cardiac surgery.Mediators Inflamm. 2007;2007:72356. doi: 10.1155/2007/72356. Mediators Inflamm. 2007. PMID: 18288274 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous